Following electroconvulsive therapy outcomes in people with severe or treatment resistant depression
Observes how electroconvulsive therapy works and affects adults with severe or treatment resistant depression.
Plain-language title generated from the registry record
Registry title: Acute Efficacy and 6 Months Follow up After Electroconvulsive Therapy
Key facts
- Where
- Bergen and Stavanger, NorwaySee the 2 sites
Where in Norway
- Haukeland University HospitalBergen, NorwayTaking people
- Stavanger University HospitalStavanger, NorwayTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Haukeland University Hospital
- Trial code
- NCT05388461
- Record updated
- 26 September 2023
- Original description
The overall aim of the current project is to assess the acute and long term outcome of ECT (both patient and clinician rated) in a non-selected patient cohort from ordinary clinical activity, and to seek out factors predicting response and remission, side effects and relapse.Read full original descriptionShow less
Acute Efficacy and 6 Months Follow up After Electroconvulsive Therapy for Severe or Treatment Resistant Depression - Predictors of Response, Side Effects, and Relapse
The overall aim of the current project is to assess the acute and long term outcome of ECT (both patient and clinician rated) in a non-selected patient cohort from ordinary clinical activity, and to seek out factors predicting response and remission, side effects and relapse.
Inclusion: Patients treated with ECT for major depression (F31.3-5, F32, F33) at Haukeland University Hospital or Stavanger University Hospital after 2013,; written consent to enrolment into the Regional Register for neurostimulation.
Exclusion: ECT performed on other indications than major depression; No consent to the register.